background


Product Information:

TD 0903

Nezulcitinib (TD-0903) is an inhaled and lung-selective pan-Janus kinase (JAK) inhibitor. Nezulcitinib can be used for the research of COVID-19 associated acute lung injury and impaired oxygenation.

Cat. No.: EX-A7156    Purity: >98%
Chemical
Chemical structure of TD 0903


For research only, Do not use for Human!

SizeUnit Price (US$)StockQuantityOrder
10mgget quoteInquire
50mgget quoteInquire
100mgget quoteInquire
200mgget quoteInquire
500mgget quoteInquire
1gget quoteInquire


SynonymsNezulcitinib
Synonyms 2THRX 136377
CAS No.2412496-23-0
Purity>98%
FormulaC30H37N7O2
Mol Weight527.6605
Statesolid powder
Shelf Life>2 years if stored properly
StoragePowder -20℃ 2 years; In solvent -20℃ 1 month;
ShippingShipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
 
 
Reference:  

[1]. Theravance's nezulcitinib fails to meet Phase II goals in Covid-19

[2]. Theravance biopharma, inc. Announces top-line results from phase 2 study of nezulcitinib in patients hospitalized with acute lung injury due to COVID-19

CoACoA of TD 0903

KEYWORDS: buy TD 0903 | TD 0903 supplier | purchase | cost | manufacturer | order | distributor | buy 2412496-23-0 | 2412496-23-0 supplier